Teva Pharmaceutical Industries Ltd (TEVA.N)
23 Feb 2018
BRIEF-Teva Announces Exclusive Launch Of Two Strengths Of A Generic Version Of Solodyn® In The United States
* TEVA ANNOUNCES EXCLUSIVE LAUNCH OF TWO STRENGTHS OF A GENERIC VERSION OF SOLODYN® IN THE UNITED STATES
Feb 20 Hikma Pharmaceuticals Plc named former Teva Pharmaceutical executive Sigurdur Olafsson as its CEO, as the Jordan-based drugmaker looks to improve its struggling generics business.
NEW YORK Warren Buffett had a Valentine’s Day surprise for investors in Teva Pharmaceutical Industries Ltd .
Warren Buffett's Berkshire Hathaway Inc on Wednesday disclosed a new stake in generic drugmaker Teva Pharmaceutical Industries Ltd and said it bought more shares of Apple Inc , which surpassed Wells Fargo & Co as its largest common stock investment. | Video
* PAULSON & CO CUTS SHARE STAKE IN ALTABA INC BY 56.1 PERCENT TO 1.7 MILLION SHARES - SEC FILING
Feb 14 Warren Buffett's Berkshire Hathaway Inc on Wednesday said it has taken a new stake in Teva Pharmaceutical Industries Ltd, significantly boosted its holdings of Apple Inc and has nearly shed a less successful investment in IBM Corp.
* BERKSHIRE HATHAWAY TAKES SPONSORED ADR STAKE IN TEVA PHARMACEUTICAL
* U.S. pricing pressure weighing on Sandoz (Adds Teva comment, share price reaction)
TEL AVIV Israel-based Teva Pharmaceutical Industries said on Tuesday it had anticipated and planned for a second generic competitor to its multiple sclerosis treatment Copaxone to enter the market in 2018.
TEL AVIV, Feb 13 Israel-based Teva Pharmaceutical Industries said on Tuesday it had anticipated and planned for a second generic competitor to its multiple sclerosis treatment Copaxone to enter the market in 2018.